HYBRID EVENT: You can participate in person at London, UK or Virtually from your home or work.

6th Edition of International Conference on Tissue Engineering and Regenerative Medicine

September 28-30 | London, UK

September 28 -30, 2026 | London, UK

Adipose Tissue and Lipogems Treatment

Adipose Tissue and Lipogems Treatment
  • Adipose Tissue and Lipogems Treatment
  • Adipose Tissue Therapy
  • Mesenchymal Stem Cells
  • Plastic Surgery
  • Lipogems and Advantages
  • Micro-Fragmented Adipose Tissue Graft

In Lipogems Treatment, human tendon stem cells (hTSCs) from the rotator cuff were cocultured in a transwell system with the Lipogems lipoaspirate product and compared to control untreated cells in terms of cell proliferation, morphology, somatic cell marker and VEGF expression, and differentiation and migration capabilities. Results showed that Lipogems product remarkably increases the proliferation rate of hTSCs without altering their stemness and differentiation capability.

Adipose tissue stem cells (ASCs), referred to as multipotent stem cells, are most ordinarily utilized in the clinical applications in recent years. Adipose tissues (AT) have the benefit within the harvesting, isolation, and expansion of ASCs, especially an abundant amount of stem cells compared to bone marrow. ASCs are often found in stromal vascular fractions (SVF) which are easily obtained from the dissociation of fat.

Committee Members
Speaker at Tissue Engineering and Regenerative Medicine 2026 - Nagy Habib

Nagy Habib

Imperial College London, United Kingdom
Speaker at Tissue Engineering and Regenerative Medicine 2026 - Lucie Bacakova

Lucie Bacakova

Institute of Physiology of the Czech Academy of Sciences, Czech Republic
Speaker at Tissue Engineering and Regenerative Medicine 2026 - Marco Polettini

Marco Polettini

DVM, Italy

Submit your abstract Today

Youtube
Watsapp